Association of polymorphisms in interleukin-8 gene with cancer risk: A meta-analysis of 22 case–control studies

OncoTargets and Therapy

Volumn 9, Issue , 2016, Pages 3727-3737

  Zhang, Meng ^a,b   Fang, Tingting ^a,b   Wang, Kai ^a,b   Mei, Hongbing ^b   Lv, Zhaojie ^b   Wang, Feng ^b   Cai, Zhiming ^b   Liang, Chaozhao ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF SHENZHEN UNIVERSITY   (China)

Author keywords

Cancer; Interleukin 8; Polymorphisms

Indexed keywords

INTERLEUKIN 8;

ARTICLE; CANCER RISK; ETHNICITY; GENE; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; IL 8 GENE; LIVER CELL CARCINOMA; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SYSTEMATIC REVIEW;

EID: 84976314201     PISSN: None     EISSN: 11786930     Source Type: Journal    
DOI: 10.2147/OTT.S103159     Document Type: Article

References (42)

1. Matsushima K, Baldwin ET, Mukaida N. Interleukin-8 and MCAF: novel leukocyte recruitment and activating cytokines. Chem Immunol. 1992;51:236-265.
2. Yuan A, Chen JJ, Yao PL, Yang PC. The role of interleukin-8 in cancer cells and microenvironment interaction. Frontiers Biosci. 2005;10: 853-865.
3. Gunter MJ, Canzian F, Landi S, Chanock SJ, Sinha R, Rothman N. Inflammation-related gene polymorphisms and colorectal adenoma. Cancer Epidemiol Biomarkers Prev. 2006;15:1126-1131.
4. Lerebours F, Vacher S, Andrieu C, Espie M, Marty M, Lidereau R, Bieche I. NF-kappa B genes have a major role in inflammatory breast cancer. BMC Cancer. 2008;8:41.
5. Zabaleta J, Su LJ, Lin HY, et al. Cytokine genetic polymorphisms and prostate cancer aggressiveness. Carcinogenesis. 2009;30:1358-1362.
6. Ren Y, Poon RT, Tsui HT, et al. Interleukin-8 serum levels in patients with hepatocellular carcinoma correlations with clinic pathological features and prognosis. Clin Cancer Res. 2003;9:5996-6001.
7. Zhang XY, Chan WY, Whitney BM, et al. Changes of interleukin expression correlate with Helicobacter pylori infection and lymph node metastases in gastric carcinoma. Diagn Mol Pathol. 2002;11:135-139.
8. Slaton JW, Inoue K, Perrotte P, et al. Expression levels of genes that regulate metastasis and angiogenesis correlate with advanced pathological stage of renal cell carcinoma. Am J Pathol. 2001;158:735-743.
9. Li A, Varney ML, Singh RK. Expression of interleukin 8 and its receptors in human colon carcinoma cells with different metastatic potentials. Clin Cancer Res. 2001;7:3298-3304.
10. Kim SJ, Uehara H, Karashima T, Mccarty M, Shih N, Fidler IJ. Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice. Neoplasia. 2001;3:33-42.
11. Huang S, Mills L, Mian B, et al. Fully humanized neutralizing antibodies to interleukin-8 (ABX-IL8) inhibit angiogenesis, tumor growth, and metastasis of human melanoma. Am J Pathol. 2002;161: 125-134.
12. Sheryka E, Wheeler MA, Hausladen DA, Weiss RM. Urinary interleukin-8 levels are elevated in subjects with transitional cell carcinoma. Urology. 2003;62:162-166.
13. Bidwell J, Keen L, Gallagher G, et al. Cytokine gene polymorphism in human disease: on-line databases, supplement 1. Genes Immun. 2001; 2:61-70.
14. Mukaida N, Shiroo M, Matsushima K. Genomic structure of the human monocyte-derived neutrophil chemotactic factor IL-8. J Immun. 1989;143:1366-1371.
15. Hull J, Thomson A, Kwiatkowski D. Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax. 2000;55:1023-1027.
16. Li K, Yao S, Liu S, Wang B, Mao D. Genetic polymorphisms of interleukin 8 and risk of ulcerative colitis in the Chinese population. Chinica Chimica Acta. 2009;405:30-34.
17. Lee E, Kim J, Zhao J, Park M, Song Y. Haplotype association of IL-8 gene with Behcet’s disease. Tissue Antigens. 2007;69:128-132.
18. Wigmore SJ, Maingay JP, Fearon KC, Ross JA. Endogenous production of IL-8 by human colorectal cancer cells and its regulation by cytokines. Int J Oncol. 2001;18:467-473.
19. Wang JL, Nong LG, Wei YS, Tang YJ, Wang JC, Wang CF. Association of interleukin-8 gene polymorphisms with the risk of hepatocellular carcinoma. Mol Biol Reports. 2014;41:1483-1489.
20. Liu CM, Yeh CJ, Yu CC, et al. Impact of interleukin-8 gene polymorphisms and environmental factors on oral cancer susceptibility in Taiwan. Oral Dis. 2012;18:307-314.
21. Koensgen D, Bruennert D, Ungureanu S, et al. Polymorphism of the IL-8 gene and the risk of ovarian cancer. Cytokine. 2015;71:334-338.
22. Ahirwar DK, Mandhani A, Mittal RD. IL-8-251 T. A polymorphism is associated with bladder cancer susceptibility and outcome after BCG immunotherapy in a northern Indian cohort. Arch Med Res. 2010; 41:97-103.
23. Savage SA, Abnet CC, Mark SD, et al. Variants of the IL8 and IL8RB genes and risk for gastric cardia adenocarcinoma and esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2004;13: 2251-2257.
24. Chien MH, Yeh CB, Li YC, et al. Relationship of interleukin-8 gene polymorphisms with hepatocellular carcinoma susceptibility and pathological development. J Surg Oncol. 2011;104:798-803.
25. Wei YS, Lan Y, Tang RG, et al. Single nucleotide polymorphism and haplotype association of the interleukin-8 gene with nasopharyngeal carcinoma. Clin Immunol. 2007;125:309-317.
26. Hsieh YY, Chang CC, Tsai CH, Lin CC, Tsai FJ. Interleukin (IL)-12 receptor beta1 codon 378 G homozygote and allele, but not IL-1 (beta-511 promoter, 3953 exon 5, receptor antagonist), IL-2 114, IL-4-590 intron 3, IL-8 3′-UTR 2767, and IL-18 105, are associated with higher susceptibility to leiomyoma. Fertil Steril. 2007;87:886-895.
27. Savage SA, Hou L, Lissowska J, et al. Interleukin-8 polymorphisms are not associated with gastric cancer risk in a Polish population. Cancer Epidemiol Biomarkers Prev. 2006;15:589-591.
28. Kamangar F, Abnet CC, Hutchinson AA, et al. Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland). Cancer Causes Control. 2006;17:117-125.
29. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-748.
30. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
31. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-1101.
32. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634.
33. Margulis AV, Pladevall M, Riera-Guardia N, et al. Quality assessment of observational studies in a drug-safety systematic review, comparison of two tools: the Newcastle-Ottawa Scale and the RTI item bank. Clin Epidemiol. 2014;6:359-368.
34. Diekstra MH, Liu X, Swen JJ, et al. Association of single nucleotide polymorphisms in IL8 and IL13 with sunitinib-induced toxicity in patients with metastatic renal cell carcinoma. Eur J Clin Pharmacol. 2015;71:1477-1484.
35. Xue H, Liu J, Lin B, Wang Z, Sun J, Huang G. A meta-analysis of interleukin-8-251 promoter polymorphism associated with gastric cancer risk. PLoS One. 2012;7:e28083.
36. Hacking D, Knight JC, Rockett K, et al. Increased in vivo transcription of an IL-8 haplotype associated with respiratory syncytial virus disease-susceptibility. Genes Immun. 2004;5:274-282.
37. Ross OA, O’Neil C, Rea IM, et al. Functional promoter region polymorphism of the proinflammatory chemokine IL-8 gene associates with Parkinson’s disease in the Irish. Human Immunol. 2004;65: 340-346.
38. Jin WJ, Xu JM, Xu WL, Gu DH, Li PW. Diagnostic value of interleukin-8 in colorectal cancer: a case-control study and meta-analysis. World J Gastroenterol. 2014;20:16334-16342.
39. Wang Z, Liu QL, Sun W, et al. Genetic polymorphisms in inflammatory response genes and their associations with breast cancer risk. Croat Medical J. 2014;55:638-646.
40. Wang N, Zhou R, Wang C, et al. 251 T/A polymorphism of the interleukin-8 gene and cancer risk: a huge review and meta-analysis based on 42 case-control studies. Mol Biol Rep. 2012;39:2831-2841.
41. Gao P, Zhao H, You J, Jing F, Hu Y. Association between interleukin-8-251A/T polymorphism and risk of lung cancer: a meta-analysis. Cancer Investig. 2014;32:518-525.
42. Li K, Yao S, Liu S, Wang B, Mao D. Genetic polymorphisms of interleukin 8 and risk of ulcerative colitis in the Chinese population. Clinica Chimica Acta. 2009;405:30-34.